PBTC-055 - Phase I/II trial of Dabrafenib, Trametinib, and Hydroxychloroquine (HCQ) for BRAF V600E-mutant or Trametinib and HCQ for BRAF fusion/duplication positive or NF1-associated recurrent or progressive gliomas in children and young adults

  • Goldman, Stewart (PD/PI)

Project: Research project

Project Details

Effective start/end date8/12/198/31/50


  • St. Jude Children's Research Hospital
  • Pediatric Brain Tumor Foundation